Dabur Guides Double-Digit Q1 Revenue And Profit Growth On Strong HPC, Foods Momentum
Dabur's Q1 FY27 update projects double-digit consolidated revenue and net profit growth, led by high-teens HPC gains (Odonil, Odomos, Fem), high double-digit Foods growth (Homemade, Badshah) and mid-single-digit healthcare, with resilient domestic and strong international demand.
What happened
Dabur's Q1 FY27 business update projects double-digit consolidated revenue and net profit growth, led by strong HPC (Odonil, Odomos, Fem), Foods (Homemade,
Key facts
- double-digit revenue growth
- double-digit net profit
- high teens HPC growth
- mid-single-digit healthcare growth
- high double-digit foods growth
Why this matters
Accelerating Foods momentum (Homemade, Badshah) and HPC leadership point to attractive bolt-on M&A and international expansion opportunities to extend the growth runway.
What to watch
- Actual reported gross and EBITDA margins vs guidance
- Volume vs price/value split in domestic revenue
- Healthcare segment trajectory and ayurvedic OTC demand
- International/constant-currency growth sustainability
- Raw material (palm oil, packaging) cost trends
- Rural vs urban demand commentary from FMCG peers
- Peers (Marico, Emami, HUL, Godrej Consumer) benchmark against Dabur's HPC/Foods print in their own updates
- Sell-side nudges FY27 estimates and target prices up on confirmed volume-led growth
- Increased ad-spend and distribution push in HPC and Foods to defend share gains
- Distributors restock ahead of festive/monsoon demand on management confidence